![Frontiers | Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia Frontiers | Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia](https://www.frontiersin.org/files/Articles/770234/fpsyt-12-770234-HTML-r3/image_m/fpsyt-12-770234-g001.jpg)
Frontiers | Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia
![Reasons for Antipsychotic Treatment Switch: A Systematic Retrospective Review of Prescription Records and Prescriber Notes | Psychiatrist.com Reasons for Antipsychotic Treatment Switch: A Systematic Retrospective Review of Prescription Records and Prescriber Notes | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2022/08/21m14272F1.jpg)
Reasons for Antipsychotic Treatment Switch: A Systematic Retrospective Review of Prescription Records and Prescriber Notes | Psychiatrist.com
Switching antipsychotics: an updated review with a focus on quetiapine - Document - Gale Academic OneFile
![Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse](https://psychscenehub.com/wp-content/uploads/2021/10/Antipsychotic-switching-strategies-Cross-titration.png)
Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse
![Recommendations for switching antipsychotics. A position statement of the Spanish Society of Psychiatry and the Spanish Society of Biological Psychiatry | Revista de Psiquiatría y Salud Mental (English Edition) Recommendations for switching antipsychotics. A position statement of the Spanish Society of Psychiatry and the Spanish Society of Biological Psychiatry | Revista de Psiquiatría y Salud Mental (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2173505011000082:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNc/fJ+DC8o0MOwKyF8OvvDTMGU2Q/NLV64hoDZoXFS+raIOJ2BvLAxcSRCYWuZKPXB63GBOQaDOJ/VMFAIewTFpcSrXoTaG5pgFNNxcFq61M+N/ftJHiWGkQge3/PBgCNcbuU3ZXXB1MJ7GIrQU/lw69dsjY4gMvxsGqxW379fAv+thuxBLyLEJJdv2CtnZy7km/kZUpGt7rU1ojXg6Ym3o7nVPdY4kv23JfUCchR7jRt0vH7zm2tmsLqgmIjftAwyPoLB5aJm9/EzGdAwO8uT4)
Recommendations for switching antipsychotics. A position statement of the Spanish Society of Psychiatry and the Spanish Society of Biological Psychiatry | Revista de Psiquiatría y Salud Mental (English Edition)
![Table IV from Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders | Semantic Scholar Table IV from Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a64edd19c743a5bff494f0a0904b2aa5e3af2598/7-TableIV-1.png)
Table IV from Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders | Semantic Scholar
![Switching and augmentation strategies for antipsychotic medications in acute-phase schizophrenia: latest evidence and place in therapy - Kotaro Hatta, Naoya Sugiyama, Hiroto Ito, 2018 Switching and augmentation strategies for antipsychotic medications in acute-phase schizophrenia: latest evidence and place in therapy - Kotaro Hatta, Naoya Sugiyama, Hiroto Ito, 2018](https://journals.sagepub.com/cms/10.1177/2045125318754472/asset/images/large/10.1177_2045125318754472-fig1.jpeg)
Switching and augmentation strategies for antipsychotic medications in acute-phase schizophrenia: latest evidence and place in therapy - Kotaro Hatta, Naoya Sugiyama, Hiroto Ito, 2018
![Post-hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long-term study (Secondary Publication). - Abstract - Europe PMC Post-hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long-term study (Secondary Publication). - Abstract - Europe PMC](https://europepmc.org/articles/PMC7722673/bin/NPR2-40-122-g001.jpg)
Post-hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long-term study (Secondary Publication). - Abstract - Europe PMC
![Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20190928053113541-0005:S1092852918001086:S1092852918001086_tab1.gif?pub-status=live)